Stock listing
LSE:0ADI Teleflex Incorporated Share Price
UK listing (LSE) of Teleflex Incorporated · home listing NYSE:TFX
Follow Teleflex Incorporated into a list and get an email when it puts out news.
Home listing price · NYSE:TFX
$161.58 USD -4.27 (-2.6%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:TFX
- Day range
- $161.47 – $166.52 USDNov 20, 2026
- Volume
- 654,988 sharesNov 20, 2026
- Market cap
- $6.85B USDAt the close on Nov 20, 2026 · price × 42.37M shares outstanding
- 52-week range
- $100.18 – $166.75 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $106.5M USDMedian day 728,100 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:TFX · Home | $161.58 USD | -4.27 (-2.6%) | 654,988 | $164.07 | $166.52 | $161.47 | $165.85 | Close on Nov 20, 2026 |
| Frankfurt:TBH | €147.30 EUR | -3.50 (-2.3%) | — | €147.30 | €147.30 | €147.30 | €150.80 | Close on Nov 20, 2026 |
| B3:T1FX34 | 62.04 BRL | 0.00 (0.0%) | — | 62.04 | 62.04 | 62.04 | 62.04 | Close on Nov 19, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NYSE:TFX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $161.58 | -4.27 | -2.6% | $164.07 | $166.52 | $161.47 | 654,988 | |
| $165.85 | +6.30 | +3.9% | $157.84 | $166.75 | $157.50 | 1,160,570 | |
| $159.55 | +2.45 | +1.6% | $156.23 | $161.00 | $156.23 | 1,588,848 | |
| $157.10 | +2.00 | +1.3% | $155.00 | $157.65 | $154.63 | 799,558 | |
| $155.10 | +1.95 | +1.3% | $153.58 | $156.30 | $153.58 | 836,376 | |
| $153.15 | -3.18 | -2.0% | $156.71 | $156.75 | $153.10 | 604,015 | |
| $156.33 | +1.03 | +0.7% | $155.93 | $156.47 | $153.99 | 610,437 | |
| $155.30 | +0.57 | +0.4% | $154.00 | $156.43 | $152.56 | 748,036 | |
| $154.73 | +3.86 | +2.6% | $151.56 | $156.21 | $148.25 | 994,006 | |
| $150.87 | -1.28 | -0.8% | $148.43 | $153.04 | $146.74 | 948,141 | |
| $152.15 | +2.28 | +1.5% | $149.43 | $156.67 | $149.14 | 1,417,531 | |
| $149.87 | +9.92 | +7.1% | $141.39 | $150.01 | $141.39 | 1,293,001 | |
| $139.95 | -0.72 | -0.5% | $141.00 | $141.85 | $137.12 | 1,266,148 | |
| $140.67 | +0.90 | +0.6% | $140.25 | $141.58 | $138.33 | 923,082 | |
| $139.77 | -1.62 | -1.1% | $142.06 | $142.70 | $138.99 | 891,273 | |
| $141.39 | +2.41 | +1.7% | $140.10 | $142.05 | $138.92 | 837,975 | |
| $138.98 | -0.02 | 0.0% | $138.03 | $140.17 | $136.92 | 630,141 | |
| $139.00 | +2.20 | +1.6% | $136.33 | $139.12 | $135.32 | 878,867 | |
| $136.80 | +0.51 | +0.4% | $134.36 | $138.06 | $130.48 | 682,906 | |
| $136.29 | -0.29 | -0.2% | $136.45 | $137.55 | $135.00 | 505,100 | |
| $136.58 | +6.18 | +4.7% | $132.30 | $137.02 | $131.27 | 698,000 | |
| $130.40 | -0.75 | -0.6% | $130.61 | $132.21 | $129.41 | 400,400 | |
| $131.15 | +1.47 | +1.1% | $130.51 | $131.89 | $129.40 | 485,100 | |
| $129.68 | -0.75 | -0.6% | $129.79 | $131.45 | $129.18 | 770,100 | |
| $130.43 | +2.21 | +1.7% | $130.14 | $131.21 | $128.69 | 838,300 | |
| $128.22 | +4.93 | +4.0% | $124.00 | $128.59 | $123.75 | 907,000 | |
| $123.29 | -1.15 | -0.9% | $123.86 | $124.89 | $123.11 | 706,500 | |
| $124.44 | -1.26 | -1.0% | $125.64 | $126.56 | $123.05 | 552,400 | |
| $125.70 | +0.58 | +0.5% | $124.74 | $126.81 | $123.74 | 621,400 | |
| $125.12 | +0.93 | +0.7% | $124.84 | $126.01 | $123.56 | 424,700 | |
| $124.19 | -0.29 | -0.2% | $124.02 | $124.95 | $122.06 | 1,001,500 | |
| $124.48 | -0.26 | -0.2% | $125.07 | $126.84 | $122.84 | 928,300 | |
| $124.74 | -0.50 | -0.4% | $125.60 | $126.94 | $123.81 | 683,300 | |
| $125.24 | +1.12 | +0.9% | $124.52 | $127.44 | $123.23 | 561,600 | |
| $124.12 | -1.99 | -1.6% | $127.12 | $127.12 | $124.01 | 647,000 | |
| $126.11 | +1.07 | +0.9% | $125.06 | $126.53 | $124.25 | 719,200 | |
| $125.04 | -1.28 | -1.0% | $126.08 | $127.06 | $124.37 | 644,700 | |
| $126.32 | -1.06 | -0.8% | $127.07 | $127.70 | $124.01 | 982,600 | |
| $127.38 | +5.31 | +4.3% | $124.26 | $128.62 | $123.52 | 1,578,200 | |
| $122.07 | +1.98 | +1.6% | $120.47 | $123.05 | $118.31 | 857,300 | |
| $120.09 | -1.66 | -1.4% | $122.34 | $123.14 | $119.86 | 869,600 | |
| $121.75 | -3.15 | -2.5% | $124.71 | $125.16 | $121.12 | 832,600 | |
| $124.90 | +0.10 | +0.1% | $126.35 | $127.07 | $124.16 | 777,100 | |
| $124.80 | +0.28 | +0.2% | $124.84 | $126.23 | $123.10 | 815,200 | |
| $124.52 | -1.07 | -0.9% | $125.03 | $125.83 | $124.01 | 1,800,700 | |
| $125.59 | -2.41 | -1.9% | $126.95 | $128.88 | $125.05 | 867,100 | |
| $128.00 | -1.02 | -0.8% | $129.13 | $130.15 | $127.72 | 827,500 | |
| $129.02 | -1.28 | -1.0% | $130.40 | $130.40 | $126.18 | 803,700 | |
| $130.30 | -0.69 | -0.5% | $132.68 | $134.27 | $129.51 | 976,900 | |
| $130.99 | -1.01 | -0.8% | $133.23 | $134.09 | $128.98 | 572,700 | |
| $132.00 | -3.72 | -2.7% | $134.96 | $135.08 | $130.99 | 763,200 | |
| $135.72 | -1.28 | -0.9% | $139.54 | $139.54 | $135.32 | 487,000 | |
| $137.00 | -1.36 | -1.0% | $136.66 | $139.11 | $134.78 | 496,100 | |
| $138.36 | -1.60 | -1.1% | $138.70 | $140.59 | $137.35 | 464,500 | |
| $139.96 | -1.01 | -0.7% | $140.01 | $143.23 | $138.64 | 704,900 | |
| $140.97 | +0.49 | +0.3% | $140.56 | $144.16 | $138.10 | 728,100 | |
| $140.48 | -1.57 | -1.1% | $140.19 | $143.05 | $135.20 | 565,000 | |
| $142.05 | +2.38 | +1.7% | $137.95 | $142.42 | $137.88 | 653,100 | |
| $139.67 | +1.96 | +1.4% | $137.35 | $140.57 | $137.35 | 429,300 | |
| $137.71 | -1.03 | -0.7% | $136.55 | $138.51 | $136.55 | 370,600 | |
| $138.74 | -1.44 | -1.0% | $139.14 | $140.17 | $137.96 | 533,800 | |
| $140.18 | +1.87 | +1.4% | $138.01 | $140.57 | $136.32 | 382,400 | |
| $138.31 | -0.52 | -0.4% | $138.87 | $140.28 | $137.71 | 645,100 | |
| $138.83 | +3.87 | +2.9% | $133.31 | $139.21 | $133.31 | 642,000 | |
| $134.96 | -0.90 | -0.7% | $135.12 | $137.28 | $134.88 | 297,000 |
Splits
5 splits since 1980 · NYSE:TFX · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 2-for-1 | Split | |
| 3-for-2 | Split | |
| 2-for-1 | Split | |
| 3-for-2 | Split | |
| 2-for-1 | Split |
- Ticker
- LSE:0ADI
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- LSE
- Currency
- USD
What changed lately
Latest news release · Nov 11, 2026
Teleflex to Present at the Jefferies Global Healthcare Conference in London
Latest earnings call · Nov 5, 2026
Teleflex (NYSE:TFX) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 5, 2026
Q3 2026 Earnings Presentation
Earnings · 37 slides
Latest news
Teleflex to Present at the Jefferies Global Healthcare Conference in London
Nov 11, 2026
Closed $156.33 (+0.7%) on Nov 11, 2026
Q3 (Q3 2026 Earnings Call Presentation FINAL)
Nov 5, 2026
Closed $152.15 (+1.5%) on Nov 5, 2026
Q3 2026 Teleflex Incorporated Earnings Call Presentation
Nov 5, 2026
Closed $152.15 (+1.5%) on Nov 5, 2026
Teleflex Announces Quarterly Dividend
Nov 5, 2026
Closed $152.15 (+1.5%) on Nov 5, 2026
Teleflex Reports Third Quarter Financial Results and Full Year 2026 Outlook
Nov 5, 2026
Closed $152.15 (+1.5%) on Nov 5, 2026
Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium Scaffold
Oct 22, 2026
Closed $136.58 (+4.7%) on Oct 22, 2026
Teleflex Announces Third Quarter 2026 Earnings Conference Call Information
Oct 22, 2026
Closed $136.58 (+4.7%) on Oct 22, 2026
Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold
Oct 12, 2026
Closed $125.70 (+0.5%) on Oct 12, 2026
Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology
Sep 29, 2026
Closed $126.32 (-0.8%) on Sep 29, 2026
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors
Sep 8, 2026
Closed $137.00 (-1.0%) on Sep 8, 2026
Teleflex Incorporated on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 34 in the last 12 months · 62 in all · newest Nov 11, 2026 · oldest 2025
- Calls
- 27 calls with a replay · 27 with a transcript · latest Nov 5, 2026
- Decks
- 129 decks · latest Nov 5, 2026
Where Teleflex Incorporated is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:TFX · Home listing | NYSE | United States | USD |
| gettex:TBH | gettex | Germany | EUR |
| BMV:TFX | BMV | Mexico | MXN |
| LS Exchange:855853 | LS Exchange | Germany | EUR |
| Lang & Schwarz:855853 | Lang & Schwarz | Germany | EUR |
| Frankfurt:TBH | Frankfurt | Germany | EUR |
| B3:T1FX34 | B3 | Brazil | BRL |
| BX Swiss:TBH | BX Swiss | Switzerland | CHF |
| Milan:1TFX | Milan | Italy | EUR |
| BOATS:TFX | BOATS | United States | USD |
| Tradegate:TBH | Tradegate | Germany | EUR |
| BIVA:TFX | BIVA | Mexico | MXN |
| Dusseldorf:TBH | Dusseldorf | Germany | EUR |
| Hanover:TBH | Hanover | Germany | EUR |
| LSE:0ADI · This page | LSE | United Kingdom | USD |
| Munich:TBH | Munich | Germany | EUR |
| Stuttgart:TBH | Stuttgart | Germany | EUR |
Valuation
P/E 22.5× against a median of 28.6×: 3rd lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $8.04B USD
- P/E
- 22.5×
- EV/sales
- 3.6×
- EV/EBITDA
- 20.1×
- Price/book
- 2.0×
- Gross margin
- 58.3%
- Operating margin
- 9.4%
- Net margin
- 13.5%
- Debt to equity
- 0.5×
- Beta vs S&P 500
- 0.50
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Teleflex Incorporated · NYSE:TFX | US$6.85B | US$8.04B | 22.5× | 3.6× | 20.1× | 2.0× | 13.5% | 0.5× | 0.50 |
| Insulet Corporation · NASDAQ:PODD | US$9.24B | US$9.62B | 21.5× | 3.0× | 13.9× | 5.8× | 13.5% | 0.6× | 0.53 |
| Globus Medical, Inc. · NYSE:GMED | US$7.48B | US$7.07B | 13.4× | 2.3× | 7.4× | 1.6× | 17.8% | 0.0× | 0.89 |
| Getinge AB Class B · OMXSTO:GETI_B | US$6.89B | US$7.68B | 24.9× | 2.3× | 11.2× | 2.1× | 8.2% | 0.3× | n/a |
| Ypsomed Holding AG · SIX:YPSN | US$6.80B | US$6.76B | 25.7× | 7.8× | 17.3× | 7.2× | 30.4% | 0.0× | n/a |
| ConvaTec Group PLC · LSE:CTEC | US$6.64B | US$8.29B | 37.9× | 3.4× | 15.2× | 4.6× | 7.2% | 1.2× | n/a |
| Cochlear Limited · ASX:COH | US$6.49B | US$6.51B | 66.6× | 4.2× | 24.2× | 5.6× | 6.3% | 0.1× | n/a |
| APT Medical Inc. Class A · SSE:688617 | US$6.00B | US$5.73B | 39.3× | 12.4× | n/a | 11.8× | 33.0% | 0.0× | n/a |
| Haemonetics Corporation · NYSE:HAE | US$5.47B | US$6.35B | 52.7× | 4.6× | 22.1× | 6.1× | 7.5% | 1.3× | 0.27 |
| Merit Medical Systems, Inc. · NASDAQ:MMSI | US$5.05B | US$5.29B | 31.6× | 3.3× | 15.4× | 2.9× | 9.9% | 0.4× | 0.49 |
| LivaNova PLC · NASDAQ:LIVN | US$5.00B | US$4.73B | 25.5× | 3.1× | 21.6× | 3.6× | 13.0% | 0.2× | 1.02 |
| Median of the others | US$6.57B | US$6.63B | 28.6× | 3.3× | 15.4× | 5.1× | 11.5% | 0.3× | 0.53 |
Forecasts
2 strong buy · 4 buy · 6 hold · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 168.09 USD · Analysts' mean
- EPS, year to Dec 2026
- 7.68 · 12 analysts
- Revenue, year to Dec 2026
- 2.26B · 12 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Jason Weidman | President and CEO |
| John Deren | Executive Vice President and Chief Financial Officer |
| Jake Newman | President and General Manager, Vascular and Emergency Medicine |
| James Ferguson | President and General Manager, Surgical |
| Kevin Robinson | President and General Manager, Anesthesia & Emergency Medicine |
| Travis Gay | President and General Manager, Interventional Urology |
| Daniel V. Logue | Corporate Vice President, General Counsel and Secretary |
| Lawrence Keusch | Vice President of Investor Relations and Strategy Development |
| Bert Lane | Vice President, Global Logistics and Distribution |
| Cameron Hicks | Corporate Vice President and Chief Human Resources Officer |
| Daniel Price | Corporate Vice President, Commercial Finance |
| Dominik Reterski | Corporate Vice President, Quality Assurance/Regulatory Affairs |
| Howard Cyr | Corporate Vice President and Chief Compliance Officer |
| James Winters | Corporate Vice President, Manufacturing & Supply Chain |
| Marie Hendrixson | Vice President, Internal Audit |
| Matt Tomkin | Corporate Vice President, Business Development |
| Matthew Howald | Vice President, Treasurer |
| Timothy Duffy | Vice President and Chief Information Officer |
| Whitney Reynolds | Vice President, Global Customer Experience |
| Sean M. Salmon | Executive |
Board
| Director | Role |
|---|---|
| Andrew A. Krakauer | Chairman of the Board |
Events
Calls
| Call | When | Status |
|---|---|---|
| Teleflex (NYSE:TFX) Q3 2026 Earnings Call | Thu, Nov 05, 2026 · 8:00 AM ET | Replay |
| Teleflex (NYSE:TFX) Q2 2026 Earnings Call | Thu, Aug 06, 2026 · 8:00 AM ET | Replay |
| Teleflex (NYSE:TFX) Q1 2026 Earnings Call | Thu, May 07, 2026 · 8:00 AM ET | Replay |
| Teleflex (NYSE:TFX) Q4 2025 Earnings Call | Thu, Feb 26, 2026 · 8:00 AM ET | Replay |
| Teleflex (NYSE:TFX) Q3 2025 Earnings Call | Thu, Nov 06, 2025 · 8:00 AM ET | Replay |
| Teleflex (NYSE:TFX) Q2 2025 Earnings Call | Thu, Jul 31, 2025 · 8:00 AM ET | Replay |
| Teleflex (NYSE:TFX) Q1 2025 Earnings Call | Thu, May 01, 2025 · 8:00 AM ET | Replay |
| Teleflex (NYSE:TFX) Q4 2024 Earnings Call | Thu, Feb 27, 2025 · 8:00 AM ET | Replay |
| Teleflex (NYSE:TFX) Q3 2024 Earnings Call | Thu, Oct 31, 2024 · 8:00 AM ET | Replay |
| Teleflex (NYSE:TFX) Q2 2024 Earnings Call | Thu, Aug 01, 2024 · 8:00 AM ET | Replay |
All 27 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 5, 2026 · Before open | +1.5% |
| Q2 2026 | Aug 6, 2026 · Before open | +1.5% |
| Q1 2026 | May 7, 2026 · Before open | +6.9% |
| Q4 2025 | Feb 26, 2026 | +9.1% |
| Q3 2025 | Nov 6, 2025 · Before open | −13.0% |
| Q2 2025 | Jul 31, 2025 · Before open | +4.9% |
| Q1 2025 | Apr 30, 2025 · Before open | −0.8% |
| Q4 2024 | Feb 27, 2025 · Before open | −21.7% |
| Q3 2024 | Oct 31, 2024 · Before open | −14.5% |
| Q2 2024 | Aug 1, 2024 · Before open | +6.8% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 2, 2024 · Before open | −6.1% |
| Q4 2023 | Feb 22, 2024 · Before open | −5.3% |
| Q3 2023 | Nov 2, 2023 · Before open | +11.6% |
| Q2 2023 | Aug 3, 2023 · Before open | −3.7% |
| Q1 2023 | May 4, 2023 · Before open | −8.5% |
| Q4 2022 | Feb 23, 2023 · Before open | −2.1% |
| Q3 2022 | Oct 27, 2022 · Before open | +1.6% |
| Q2 2022 | Jul 28, 2022 · Before open | −7.8% |
| Q1 2022 | Apr 28, 2022 · Before open | −6.5% |
| Q4 2021 | Feb 24, 2022 · Before open | +4.9% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 37 slides | Nov 5, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 35 slides | Aug 6, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 28 slides | May 7, 2026 |
| FY2025 Earnings Presentation | Earnings | 36 slides | Feb 26, 2026 |
| Investor Day (November 2025) | Investor day | 19 slides | Nov 14, 2025 |
| Q3 2025 Earnings Presentation | Earnings | 34 slides | Nov 6, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 33 slides | Jul 31, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 27 slides | May 1, 2025 |
| Merger or Acquisition (February 2025) | Merger or acquisition | 26 slides | Feb 27, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 28 slides | Feb 27, 2025 |
Show 50 decks
This page holds 50 of 129 decks. Open Decks
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.99B | 1.70B | 1.71B | 2.79B | 2.81B | 2.54B | 2.60B | 2.45B | 2.15B | 1.87B |
| Cost of revenue | 872.0M | 662.2M | 672.3M | 1.26B | 1.26B | 1.21B | 1.19B | 1.15B | 974.5M | 871.8M |
| Gross profit | 1.12B | 1.04B | 1.04B | 1.53B | 1.55B | 1.32B | 1.41B | 1.30B | 1.17B | 996.2M |
| Research and development | 144.8M | 109.0M | 113.6M | 153.8M | 130.8M | 119.7M | 113.9M | 106.2M | 84.8M | 58.6M |
| Selling, general and administrative | 720.2M | 674.5M | 622.7M | 863.7M | 860.1M | 743.6M | 851.8M | 797.1M | 700.0M | 563.3M |
| Operating income | 118.4M | 103.7M | 258.7M | 499.7M | 628.1M | 423.1M | 427.3M | 321.7M | 372.3M | 319.5M |
| Depreciation and amortization | 177.7M | 161.5M | 148.1M | 230.6M | 237.4M | 227.3M | 218.4M | 214.7M | 160.3M | 128.3M |
| EBITDA | 296.1M | 265.2M | 406.8M | 730.3M | 865.5M | 650.3M | 645.6M | 536.4M | 532.6M | 447.8M |
| Interest expense | 100.2M | 83.5M | 85.1M | 54.3M | 57.0M | 66.5M | 80.3M | 103.0M | 82.5M | 54.9M |
| Income before tax | 24.6M | 26.3M | 185.4M | 445.9M | 559.5M | 357.7M | 339.9M | 219.6M | 284.9M | 245.7M |
| Income tax | -34.0M | -30.9M | 41.9M | 83.0M | 74.3M | 21.9M | -122.1M | 23.2M | 129.6M | 8.07M |
| Net income | -905.6M | 69.7M | 356.3M | 363.1M | 485.4M | 335.3M | 461.5M | 200.8M | 152.5M | 237.4M |
| Earnings per share, basic | -20.30 | 1.49 | 7.58 | 7.74 | 10.38 | 7.21 | 9.99 | 4.39 | 3.39 | 5.48 |
| Earnings per share, diluted | -20.25 | 1.48 | 7.53 | 7.68 | 10.23 | 7.09 | 9.80 | 4.29 | 3.27 | 4.98 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 378.6M | 247.9M | 222.8M | 292.0M | 445.1M | 375.9M | 301.1M | 357.2M | 333.6M | 543.8M |
| Short-term investments | 16.0M | 16.9M | 48.5M | 21.7M | 20.1M | 21.6M | 14.7M | 0 | 0 | |
| Receivables | 345.6M | 226.7M | 443.5M | 408.8M | 383.6M | 395.1M | 418.7M | 366.3M | 345.9M | 272.0M |
| Inventory | 404.4M | 306.8M | 626.2M | 578.5M | 477.6M | 513.2M | 476.6M | 427.8M | 395.7M | 316.2M |
| Current assets | 1.94B | 1.47B | 1.41B | 1.41B | 1.43B | 1.42B | 1.31B | 1.24B | 1.13B | 1.18B |
| Property, plant and equipment | 498.3M | 308.5M | 479.9M | 447.2M | 443.8M | 473.9M | 430.7M | 432.8M | 383.0M | 302.9M |
| Goodwill | 2.31B | 1.99B | 2.91B | 2.54B | 2.50B | 2.59B | 2.25B | 2.25B | 2.24B | 1.28B |
| Total assets | 6.95B | 7.10B | 7.53B | 6.93B | 6.87B | 7.15B | 6.31B | 6.28B | 6.18B | 3.89B |
| Accounts payable | 130.2M | 97.9M | 132.2M | 126.8M | 118.2M | 102.5M | 102.9M | 106.7M | 92.0M | 69.4M |
| Current liabilities | 762.0M | 649.4M | 606.7M | 581.5M | 680.1M | 540.0M | 563.1M | 582.5M | 483.9M | 427.6M |
| Long-term debt | 2.54B | 1.56B | 1.73B | 1.62B | 1.74B | 2.38B | 1.86B | 2.07B | 2.16B | 850.3M |
| Total debt | 2.64B | 1.66B | 1.82B | 1.71B | 1.85B | 2.48B | 1.91B | 2.16B | 2.25B | 1.03B |
| Total liabilities | 3.82B | 2.82B | 3.09B | 2.91B | 3.12B | 3.82B | 3.33B | 3.74B | 3.75B | 1.75B |
| Shareholders' equity | 3.12B | 4.28B | 4.44B | 4.02B | 3.75B | 3.34B | 2.98B | 2.54B | 2.43B | 2.14B |
| Shares outstanding | 39.7M | 39.7M | 44.2M | 44.2M | 46.4M | 47.1M | 46.9M | 46.9M | 46.7M | 46.0M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 96.7M | 301.9M | 206.1M | 342.8M | 652.1M | 437.1M | 437.1M | 435.1M | 426.3M | 410.6M |
| Capital spending | -95.2M | -90.4M | -46.4M | -79.2M | -71.6M | -90.7M | -102.7M | -80.8M | -70.9M | -53.1M |
| Free cash flow | 1.45M | 211.4M | 159.7M | 263.6M | 580.5M | 346.4M | 334.4M | 354.3M | 355.4M | 357.5M |
| Cash from investing | -812.7M | -63.4M | 27.3M | -259.4M | 156.7M | -837.8M | -73.5M | -196.4M | -1.83B | -57.0M |
| Cash from financing | 611.5M | -421.9M | 38.5M | -217.5M | -715.8M | 455.2M | -418.8M | -206.4M | 1.14B | -118.7M |
| Dividends paid | -60.3M | -63.5M | -63.9M | -63.8M | -63.6M | -63.2M | -62.8M | -62.2M | -61.2M | -59.0M |
| Share buybacks | -300.0M | -200.0M | 0 | 0 | 412.5M | 19.0M | 21.2M | 22.7M | 5.57M | 9.07M |
| Change in cash | 126.2M | 104.8M | -69.2M | -153.1M | 69.2M | 74.8M | -56.1M | 23.6M | -210.2M | 205.4M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 16, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2026 | Results | SEC |
| 4 · Change in ownership | Sep 10, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 10, 2026 | Insider trade | SEC |
| 8-K · Current report | Sep 8, 2026 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Sep 8, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Aug 7, 2026 | Current report | SEC |
| 10-Q · Quarterly report | Aug 6, 2026 | Quarterly report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Aug 6, 2026 | Results | SEC |
| 8-K/A · Current report, amended | Aug 5, 2026 | Current report | SEC |
| 8-K · Current report | Aug 3, 2026 | Acquisition or disposal | SEC |
| 11-K · Annual report of an employee plan | Jun 26, 2026 | Annual report | SEC |
| 8-K · Current report | Jun 15, 2026 | Material contract | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 9, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 9, 2026 | Management or board change | SEC |
| 8-K · Current report | Jun 1, 2026 | Current report | SEC |
| 8-K · Current report | Jun 1, 2026 | Current report | SEC |
| SD · Specialized disclosure | May 28, 2026 | ESG report | SEC |
| 8-K · Current report | May 27, 2026 | Material contract | SEC |
| 8-K · Current report | May 20, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 18, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | May 12, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 7, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 7, 2026 | Results | SEC |
| 8-K · Current report | Apr 30, 2026 | Management or board change | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 30, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 29, 2026 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Apr 13, 2026 | Insider trade | SEC |
| ARS · Annual report to shareholders | Apr 13, 2026 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 13, 2026 | Meeting notice | SEC |
| 8-K · Current report | Mar 27, 2026 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Mar 17, 2026 | Current report | SEC |
| 4 · Change in ownership | Mar 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 10-K · Annual report | Feb 27, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 26, 2026 | Results | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 12, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 11, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Jan 23, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Jan 15, 2026 | Insider trade | SEC |
| 8-K · Current report | Jan 8, 2026 | Results | SEC |
| 8-K · Current report | Dec 9, 2025 | Material contract | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 14, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 6, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 17, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 7, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Jul 31, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jul 31, 2025 | Results | SEC |
| 8-K · Current report | Jun 27, 2025 | Material contract | SEC |
| 11-K · Annual report of an employee plan | Jun 27, 2025 | Annual report | SEC |
| SD · Specialized disclosure | May 29, 2025 | ESG report | SEC |
| 8-K · Current report | May 15, 2025 | Meeting outcome | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 14, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 7, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | May 1, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 1, 2025 | Results | SEC |
| 4 · Change in ownership | Apr 3, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 3, 2025 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Mar 28, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Mar 28, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 28, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 8-K · Current report | Mar 3, 2025 | Current report | SEC |
| 10-K · Annual report | Feb 28, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 27, 2025 | Results | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 5, 2025 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 8, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 7, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Oct 31, 2024 | Quarterly report | SEC |
| 8-K · Current report | Oct 31, 2024 | Results | SEC |
| 8-K · Current report | Aug 29, 2024 | Current report | SEC |
| 4 · Change in ownership | Aug 27, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 16, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 16, 2024 | Other filings | SEC |
| 8-K · Current report | Aug 5, 2024 | Current report | SEC |
| 10-Q · Quarterly report | Aug 2, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 1, 2024 | Results | SEC |
| 11-K · Annual report of an employee plan | Jun 28, 2024 | Annual report | SEC |
| 4/A · Change in ownership, amended | Jun 20, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jun 20, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jun 20, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jun 20, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jun 20, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jun 20, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jun 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 20, 2024 | Insider trade | SEC |
| SD · Specialized disclosure | May 30, 2024 | ESG report | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 8-K · Current report | May 9, 2024 | Management or board change | SEC |
| 10-Q · Quarterly report | May 3, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 2, 2024 | Results | SEC |
| ARS · Annual report to shareholders | Apr 5, 2024 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 1, 2024 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 1, 2024 | Other filings | SEC |
| 4 · Change in ownership | Feb 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 28, 2024 | Insider trade | SEC |
| 10-K · Annual report | Feb 23, 2024 | Annual report | SEC |
| 8-K · Current report | Feb 22, 2024 | Results | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 9, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 8, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 24, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Dec 29, 2023 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 27, 2023 | Other filings | SEC |
| 4 · Change in ownership | Dec 22, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 15, 2023 | Insider trade | SEC |
| SC 13G · Big-stake notice | Dec 7, 2023 | Big-stake notice | SEC |
This page holds 200 of 1,008 filings. Open Filings
Cap table
Built by 6ix from Teleflex Incorporated’s releases
- Common shares
- 42,372,397
- Fully diluted
- 42,372,397
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 42,372,397 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 42,372,397 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Richard A Meier Other companies: BioMarin Pharmaceutical Inc. (Director · Since at least Dec 14, 2006); Rockley Photonics Holdings Ltd (President & CFO · Oct 20, 2022 – Oct 21, 2022 · Past); Intersect ENT Inc (EVP & Chief Financial Officer · Nov 26, 2019 – May 13, 2022 · Past); Accendra Health, Inc. (EVP, Chief Financial Officer · Mar 1, 2013 – Feb 8, 2018 · Past); STAAR Surgical Company (Director · Jun 25, 2009 – May 19, 2016 · Past); Advanced Medical Optics Inc (President and COO · May 24, 2006 – Aug 6, 2008 · Past) | Exec. Vice Pres. and CFO · Jan 11, 2010 – Feb 28, 2012 · Past |
| Kevin Gordon Other companies: Progyny, Inc. (Director · Since at least Oct 24, 2019); Veracyte, Inc. (Director · Dec 12, 2016 – Jun 8, 2022 · Past); IQVIA Holdings, Inc. (EVP and COO · May 8, 2013 – Jun 9, 2016 · Past) | Exec. Vice Pres. & CFO · Dec 25, 2005 – Dec 31, 2009 · Past |
| W Kim Foster Other companies: Hexcel Corporation (Director · May 10, 2007 – Jul 6, 2018 · Past); JLG Industries Inc (Director · Dec 6, 2006 – Dec 6, 2006 · Past); FMC Corporation (Executive VP and CFO · Feb 23, 2006 – Mar 2, 2012 · Past) | Director · May 3, 2013 – May 16, 2018 · Past |
| Benson Smith Other companies: Zoll Medical Corp (Director · Nov 14, 2006 – Apr 26, 2012 · Past); Rochester Medical Corporation (Director · Jan 26, 2006 – Dec 26, 2012 · Past) | Director · Feb 22, 2006 – Feb 18, 2020 · Past |
| Candace H Duncan Other companies: FTD Companies Inc (Director · Jun 5, 2018 – Jun 5, 2018 · Past); Discover Financial Services (Director · May 2, 2018 – May 15, 2025 · Past) | Director · Since at least May 16, 2018 |
| Gretchen Haggerty Other companies: Atmus Filtration Technologies Inc. (Director · Since at least May 14, 2024); Johnson Controls International plc (Director · Since at least Mar 9, 2024) | Director · Since at least May 7, 2024 |
| Michael J. Tokich Other companies: Mettler-Toledo International, Inc. (Director · Since at least Jan 20, 2026); STERIS plc (Ireland) (Sr. Vice Pres., CFO · Since at least Apr 7, 2022) | Director · Since at least May 15, 2026 |
| Patricia C Barron Other companies: Ultralife Corporation (Director · Nov 19, 2008 – Nov 15, 2012 · Past); Quaker Houghton (Director · Oct 1, 2008 – Aug 10, 2015 · Past) | Director · Nov 21, 2008 – Feb 23, 2017 · Past |
| Sean Salmon Other companies: Adagio Medical Holdings, Inc (Director · Since at least Dec 11, 2025); Medtronic plc. (EVP & President Cardiovascular · Nov 1, 2019 – Dec 16, 2024 · Past) | Executive · Since at least Sep 8, 2026 |
| Stephen Klasko Other companies: DocGo Inc. (Director · Since at least Oct 1, 2024); Health Assurance Acquisition Corp (Director · Nov 12, 2020 – Nov 12, 2020 · Past) | Chairman of the Board · Oct 2, 2017 – Nov 5, 2026 · Past |
All 47 people
| Person | Seat |
|---|---|
| Stuart Randle Other companies: Decoy Therapeutics Inc. (Director · Jan 28, 2015 – Jul 25, 2018 · Past); Beacon Roofing Supply Inc (Director · Feb 15, 2006 – May 23, 2024 · Past) | Director · Since at least May 1, 2009 |
| Andrew A. Krakauer Other companies: Cantel Medical Corp (CEO, Director · Oct 13, 2006 – Dec 28, 2015 · Past) | Chairman of the Board · Since at least Jan 1, 2018 |
| Charles Edward Williams Other companies: IQVIA Holdings, Inc. (Sr VP and Controller · May 8, 2013 – Mar 3, 2017 · Past) | Corp. Controller and CAO · Sep 19, 2006 – Mar 4, 2011 · Past |
| Clark D Handy Other companies: Convergys Corporation (SVP Human Resources · Dec 11, 2006 – Jun 18, 2010 · Past) | Exec.Vice Pres. · Dec 25, 2005 – Nov 16, 2006 · Past |
| Jaewon Ryu Other companies: Privia Health Group, Inc. (Director · Since at least Jun 30, 2021) | Director · Since at least May 5, 2023 |
| John C Heinmiller Other companies: St. Jude Medical Inc (Executive Vice President · Dec 12, 2006 – Jan 4, 2017 · Past) | Director · Jan 1, 2019 – May 9, 2025 · Past |
| Liam J. Kelly Other companies: Enovis Corporation (Director · Since at least Jan 1, 2020) | Chairman, President & CEO, Director · Since at least Feb 26, 2014 |
| Neena M Patil Other companies: Jazz Pharmaceuticals plc (EVP & Chief Legal Officer · Since at least Jul 29, 2019) | Director · Since at least Apr 29, 2022 |
| Richard A Packer Other companies: Bruker Corporation (Director · Since at least Dec 16, 2019) | Director · May 7, 2019 – May 4, 2021 · Past |
| William Roland Cook Other companies: Quaker Houghton (Director · Jun 1, 2006 – Nov 20, 2017 · Past) | Director · Feb 22, 2006 – Aug 12, 2016 · Past |
| Bert Lane | Vice President, Global Logistics and Distribution · Since at least Nov 5, 2026 |
| Cameron Hicks | Corporate Vice President and Chief Human Resources Officer · Since at least Dec 8, 2014 |
| Daniel Price | Corporate Vice President, Commercial Finance · Since at least Nov 5, 2026 |
| Daniel V. Logue | Corporate Vice President, General Counsel and Secretary · Since at least Feb 23, 2026 |
| Dominik Reterski | Corporate Vice President, Quality Assurance/Regulatory Affairs · Since at least Apr 1, 2026 |
| Howard Cyr | Corporate Vice President and Chief Compliance Officer · Since at least Nov 5, 2026 |
| Jake Newman | President and General Manager, Vascular and Emergency Medicine · Since at least Sep 29, 2026 |
| James Ferguson | President and General Manager, Surgical · Since at least May 13, 2025 |
| James Winters | Corporate Vice President, Manufacturing & Supply Chain · Since at least Feb 18, 2020 |
| Jason Weidman | President and CEO · Since at least Apr 30, 2026 |
| Jay White | CVP & Pres, Global Commercial · Feb 23, 2021 – Mar 4, 2025 · Past |
| John Deren | Executive Vice President and Chief Financial Officer · Since at least Feb 23, 2018 |
| Julie McDowell | Sr. VP Corp. Communic. · Feb 26, 2008 – Mar 4, 2008 · Past |
| Kevin Robinson | President and General Manager, Anesthesia & Emergency Medicine · Since at least Apr 30, 2025 |
| Laurence G Miller | EVP, Chf Admin Off, GC & Sec'y · Dec 25, 2005 – Mar 18, 2013 · Past |
| Lawrence Keusch | Vice President of Investor Relations and Strategy Development · Since at least Sep 4, 2026 |
| Marie Hendrixson | Vice President, Internal Audit · Since at least Nov 5, 2026 |
| Mario Wijker | Vice President, QARA · Feb 18, 2020 – Feb 25, 2020 · Past |
| Matthew Howald | Vice President, Treasurer · Since at least Nov 5, 2026 |
| Matt Tomkin | Corporate Vice President, Business Development · Since at least Nov 5, 2026 |
| Sigismundus W W Lubsen | Director · Feb 22, 2006 – Mar 16, 2015 · Past |
| Teleflex Lawrence Keusch | Vice President, Investor Relations and Strategy Development · Sep 11, 2025 – Nov 4, 2026 · Past |
| Thomas E Powell | Executive Vice President & CFO · Feb 23, 2018 – Apr 1, 2025 · Past |
| Timothy Duffy | Vice President and Chief Information Officer · Since at least Nov 5, 2026 |
| Travis Gay | President and General Manager, Interventional Urology · Since at least May 21, 2026 |
| Vincent Northfield | Exec. VP - Global Ops-Medical · Dec 12, 2005 – Mar 8, 2011 · Past |
| Whitney Reynolds | Vice President, Global Customer Experience · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Teleflex Incorporated.